A phase I study of zoledronic acid (Zometa) with cyclophosphamide in children with recurrent or refractory neuroblastoma and cortical bone involvement (NANT 2004-01).

Trial Profile

A phase I study of zoledronic acid (Zometa) with cyclophosphamide in children with recurrent or refractory neuroblastoma and cortical bone involvement (NANT 2004-01).

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Zoledronic acid (Primary) ; Cyclophosphamide
  • Indications Neuroblastoma
  • Focus Adverse reactions
  • Most Recent Events

    • 14 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 14 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 14 May 2012 Actual patient number 21 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top